NexImmune to Present at the 2021 Cantor Virtual Global Healthcare Conference

NEXT STORY
Ziopharm Oncology Announces Strategic Reduction in Workforce and Extension in Cash Runway
PREV STORY
INmune Bio, Inc. to Participate in the B. Riley Fall 2021 Best Ideas in Oncology Series
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Biocartis Group NV: Biocartis announces 2018 half-year results on 6 September 2018

PRESS RELEASE: REGULATED INFORMATION Thursday 30 August 2018, 07:00 CEST BIOCARTIS ANNOUNCES 2018 HALF-YEAR RESULTS ...

author_avatar
NASDAQ Market News

Aduro Announces Milestone Achieved under Merck Collaboration for Initiation of Anti-CD27 Phase I Trial in Advanced Solid Tumors

BERKELEY, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced ...

author_avatar
NASDAQ Market News

Cellectar Files IND for Phase 1 Trial of CLR 131 in Pediatric Cancers

MADISON, Wis., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), a clinical-stage ...

author_avatar
NASDAQ Market News